COVID-19 antibody drugs not as effective against omicron variant, preliminary tests show 0 (0)

Regeneron and Lilly antibody drug cocktails reportedly lose effectiveness against the omicron variant
This according to a WSJ report, with Regeneron saying that its COVID-19 antibody drug cocktail was found to lose effectiveness against omicron based on preliminary tests. Adding that perhaps there needs to be a modification if the new strain becomes widespread.

Go to Forexlive

Risk trades breathe a little easier so far on the session 0 (0)

Calmer tones prevail after Friday’s rout
European indices are up 0.3% to 0.7% while S&P 500 futures are up 0.6% as risk trades are holding up so far on the day. The Omicron variant worries are still the main thing to watch out for but as mentioned earlier, essentially „no news is good news“.

Go to Forexlive